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Abstract
Purpose of Review Although treatment algorithms and parameters for best practice are readily available for all major syndromes
of psychiatric impairment, the occurrence of psychiatric syndromes in individuals with intellectual and developmental disability
(IDD) invokes serious contextual challenges for interpretation of symptoms, diagnosis, and optimization of treatment, both for
clinicians and for the service sectors in which care and support of individuals with IDD are delivered. Recognizing that there exist
very few definitive resources for best practice under the circumstance of this form of “dual diagnosis,” the Missouri Department
of Mental Health convened an expert panel to conduct a focused review and synthesis of the relevant scientific literature from
which to develop guidance in the form of decision support to clinicians. This article summarizes the findings for three of the most
common and impairing clusters of psychiatric symptoms that co-occur with IDD—aggression, depression, and addictions.
Recent Findings Individuals with IDD are at high risk for the development of psychiatric symptoms (PS), which often manifest
uniquely in IDD and for which evidence for effective intervention is steadily accruing.
Summary Interventions that are commonly implemented in the IDD service sector (e.g., functional communication training and
positive behavioral support planning) are capable of mitigating severe behavioral impairment, yet rarely invoked when dual
diagnosis patients are seen in the psychiatric service sector. Conversely, state-of-the-art interventions for traumatic stress,
pharmacotherapy, and psychotherapy have proven capable of improving behavioral impairments in IDD but are typically
restricted to the psychiatric service sector, where there exist significant barriers to access for patients with IDD, including
limitations imposed by diagnostic eligibility and practitioner experience. Bridging these gaps in knowledge and clinical capacity
across the respective IDD and PS service sectors should be of very high priority in strategizing the care and support of IDD
patients with serious co-occurring psychiatric conditions.
Keywords Comorbidity . Psychiatric services . Diagnosis . Treatment

All authors are members of the Missouri DMH Dual Diagnosis Task Force,
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Introduction

This article is part of the Topical Collection on Autism Spectrum
Disorders

Although there have been extensive reviews of the literature
on the clinical treatment of individual developmental and psychiatric disorders, there is much less information on the approach to patients with combined intellectual/developmental
disabilities (IDD) and psychiatric syndromes (PS). Despite the
limited literature on combined presentations, individuals with
IDD are at a disproportionately high risk of developing PS
[1–7]. The high level of unmet clinical needs of individuals
with such comorbidities is compounded by the fragmentation
of the municipal systems designated for their care, which are
commonly fragmented into separate and nonoverlapping
bureaucracies—one for developmental disability and another
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for behavioral health services. Since patients with dual diagnoses may have severe and persistent impairments in adaptive
function (a glossary for definitions of this and other selected
terms is provided in Table 1), they are often heavily reliant on
governmental systems of care. Lack of knowledge and experience [8], and insufficient clinical infrastructure for patients
with multiple disabilities results in less effective services and
interventions that too-often fail to meet the needs of individuals with co-occurring IDD and PS.
Current understanding of the causal origins of neuropsychiatric disorders reinforces epidemiologic evidence that comorbidity of PS occurs disproportionately among patients with
IDD and that these two domains of neuropsychiatric impairment often overlap with respect to traceable molecular genetic
causes [9, 10]. The notion of pleiotropy implies that specific
genetic, environmental, and behavioral liabilities can contribute
to the development of disparate disorders that cross the boundaries of what has traditionally divided IDD from PS. This newly established understanding of biological overlap, coupled
with overwhelming epidemiologic evidence of the common
co-occurrence of IDD and PS, calls into question traditional
categorizations (IDD versus PS) for the purpose of intervention
and service planning and, as we will elaborate below, typically
results in only partial applications of best clinical practice [11•].
For many patients, the development of higher-impact treatment
will require joint implementation of interventions traditionally
relegated to one domain or the other. Moreover, capitalizing on
knowledge of how PS manifests uniquely in IDD and how it can
arise from consequences of IDD that are distinct from those in
neurotypical individuals (individuals that are not affected with a
Table 1

developmental disorder) with PS may well improve approaches
to effective treatment, carrying the potential for (i) preventing
enduring or entrenched trajectories of behavioral impairment;
(ii) improving quality of life; and (iii) avoiding unnecessary
polypharmacy or placement in overly restrictive environments.
The emergence of PS in individuals with IDD poses many
serious challenges for interpretation of symptoms, diagnosis,
and optimization of treatment, both for clinicians and for the
service sectors which deliver care to support such individuals.
Fortunately, serious efforts to establish expert consensus on
refining the application of psychiatric diagnostic criteria to
patients with intellectual disability has resulted in an important
resource for clinicians now in its second edition, the
Diagnostic Manual-Intellectual Disability (DM-ID-2), published by the National Association for Dual Diagnosis.
Recognizing, however, that there exist very few definitive
resources for best practice under the circumstance of this form
of “dual diagnosis,” the Missouri Department of Mental
Health recently convened an expert multidisciplinary panel
to conduct a focused review of the relevant scientific literature
and to develop guidance in the form of clinical decision support for three of the most common and impairing clusters of
psychiatric symptoms that co-occur with IDD—aggression,
depression, and the addictions—within the context of two
major categories of IDD: intellectual disability, autism spectrum disorder, and their combination. One of the obvious complexities in any attempt to develop assessment and intervention guidelines for dual diagnosis is the wide variation in IDD
severity within the population. For example, DSM-5 parameterizes the degree of impairment of autism spectrum disorder

Glossary of terms

Glossary
Adaptive function

Functional behavior assessment

Functional communication training

Neurotypical
Noncontingent reinforcement
without extinction

“The child’s performance across socialization, communication, and daily living domains” [9]. Deficits in adaptive
function may be influenced by symptoms of a condition but differ from symptoms in that they relate to general
aspects of maturity and homeostasis that allow an individual to direct the course of his/her own behavior, pursue
goals, maintain safety, contribute to the community through work and social interaction, and engage in fulfilling
interpersonal relationships
Involves evaluation of the behavior and of the antecedent and consequences associated with the behavior. An
assessment analyzes the precipitants of the behavior and proposes hypotheses about factors that control the
behavior. The information gathered guides the intervention by altering conditions so that the desired behaviors
are shaped and reinforced [10]
Functional communication training involves teaching a socially appropriate communicative response that serves
the same function as a problem behavior and therefore serves as a substitute for problem behavior. A functional
analysis is conducted to identify the environmental events that serve as reinforcers for the problem behavior and
the conditions that evoke problem behavior. A socially appropriate communicative response is selected and
taught with prompting and a schedule of reinforcement that results in the appropriate response replacing the
problem behavior. An example of this would include training a child to say, “help please” when engaged in a
difficult task rather than screaming [11•]
Exhibiting or characteristic of typical neurological development; i.e. pertaining to individuals who are not affected
by a neurodevelopmental disorder
Includes the delivery of a reinforcer on a time-based schedule that does not depend on the individual’s adaptive or
maladaptive behavior. For example, noncontingent reinforcement without extinction may involve allowing an
individual to access preferred items every 30 s, irrespective of the individual’s behavior, and without any
specific contingency for the preferred item that would operate to extinguish a maladaptive behavior [12]
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(ASD) according to level of necessary support (requiring support, substantial support, or very substantial support). This stratification does not necessarily result in actionable categorizations relating to an individual’s functional communication
skills, cognitive/developmental abilities (including presence of
intellectual disability, which co-occurs with ASD in about 25%
of patients), and daily living skills. Moreover, an individual’s
age and developmental level (infancy, early childhood, school
age, adolescence, adulthood, senescence) must also be considered in any algorithm for identifying and treating PS.

Precipitating Factors for Psychiatric Symptoms
Complicated by the Context of Developmental
Disability
An irony for what are considered “hard-wired”
neurodevelopmental disorders is that they render many individuals affected by IDD exquisitely sensitive to changes in the
environment. Abrupt changes in social, residential, or caregiving environments are common precipitants for the emergence
of PS among individuals with IDD. These precipitants can
generate a disruption in routine, induce a change in access to
rewards in the environment, produce a feeling of loss when a
caregiver or beloved staff member rotates off service, and
disrupt nuances in stimulus characteristics that may be idiosyncratically aversive or rewarding and therefore highly influential. PS can also arise in the context of an individual’s first
recognition of his/her own differences from peers, including
identification of skill deficits related to vulnerability. These
may include deficits in assertiveness, communication, social
competence, and/or educational achievement. Negative peer
interactions have been shown to exert independent adverse
effects, especially on children with high-functioning ASD
who are commonly bullied, teased, or ostracized in educational settings. Social affiliation may be further compromised if an
affected individual perseverates or is prone to intense absorption with repetitive behaviors or internal preoccupation and
when peers and caregivers are unsure of how to promote the
individual’s social engagement and inclusion. Exhaustion or
the unmet mental health needs of parents and caregivers can
have profound effects on the behavior of individuals with
IDD. In all of these scenarios and as in the customary approach to adjustment disorders in psychiatric practice, attention to the environment is critical. Restoring the support previously derived from the environment is a first principle in the
care of individuals with IDD who experience or manifest new
psychiatric symptoms, even when those symptoms appear
disproportionate to the expected impact of the antecedent environmental change. There may be times when it is difficult or
impossible to restore previous levels of support for individuals
with IDD, such as the loss of a caregiver or a required change
in placement. In these instances, a new baseline for the individual’s behavior should be established, and time to adjust to a

new routine or environment should be afforded prior to a
significant change in treatment. Premature implementation
of pharmacotherapy or specific behavior intervention in this
context can be inefficient and off-target in relation to the origin
of the presenting symptoms.

Unique Considerations of Trauma in IDD
Similarly, trauma is a common causal factor in the emergence
of “phenocopies” of psychiatric syndromes occurring in patients with IDD in whom traumatic events may have gone
unrecognized for years due to the victims’ inability to articulate memories or any accounts of their occurrence. A global
paradigm shift is occurring that embraces a trauma-informed
approach based on more than two decades of research showing a strong correlation between ACEs (Adverse Childhood
Experiences) and long-term health and social outcomes.
Specifically, studies have estimated that having a chronic
health condition, including an IDD, is associated with having
an 83% higher likelihood of a child experiencing 2 or more
ACEs and 73% higher likelihood of experiencing 3 or more
ACEs by the age of five [12]. Externalizing behavior, which
has a greater incidence among children with IDD, can be
related to an increased risk of physical abuse, whereas internalizing behavior or communication and learning problems
may be related to increased risk of sexual abuse [13, 14].
Even individuals with subclinical traits of ASD are substantially more commonly victimized by physical, sexual, emotional abuse, or neglect than those without these traits in the
general population [15]. During adolescence, the sexual development of children with IDD is often misunderstood or
stereotyped as asexual or hypersexual which may increase
the risk of exposure to sexual abuse. According to a study
conducted by the National Survey of Children’s Health
(NSCH), children with IDD are bullied 1.5 to 2 times more
than their peers without IDD [16]. Additionally, children with
IDD are exposed to traumatizing incidents of physical restraint and seclusion which are not typically experienced by
their peers without IDD [17]. Emotional neglect, serious injury, property crime, out-of-home placements, and disrupted
treatment are other examples of traumatic events disproportionately experienced by children with IDD. Children and
youth with IDD are up to 4 times more likely to witness family
domestic violence in comparison to controls [18]. According
to a study on the prevalence of various types of ACEs experienced by children with IDD, the most frequent were parental
separation/divorce (63.8%), parental mental health problems
(33.3%) and to have witnessed violence against a parent
(28.9%) [19].
In the same way that the presence of IDD may lead service
providers to minimize or overlook the presence of PS, the
impact of traumatic experiences can be similarly discounted
for individuals with IDD [20, 21]. Children and youth with co-
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occurring IDD and PS who are admitted to inpatient acute care
are at significant risk for long-term institutionalization [22].
Recognition of traumatic experiences requires a high level of
vigilance on the part of clinicians, given that patients with
IDD may struggle to directly communicate traumatic experiences and because events commonly construed as relatively
trivial can be experienced as traumatic by the individual.
Clinicians trained to diagnose posttraumatic stress disorder
(PTSD), as originally defined in the Diagnostic and
Statistical Manual for Mental Disorders (DSM) for an adult
population such as combat veterans and burn victims, may not
readily recognize the clinical symptoms of PTSD in traumatized individuals with IDD. Symptom expression tends to be
complicated by cognitive, affective, social, or physical differences [23]. Since communication is often hindered in this
population, it is important to observe changes in behavior
and function in considering PTSD: hypervigilance or flashbacks can manifest as agitation; autonomic hyperarousal as
overt aggression, disruptive behavior, or self-harm; and nightmares as unexplained sleep problems [21]. It is for these reasons that providers working with children and youth with cooccurring IDD and PS should apply a trauma-informed perspective to aid in diagnosis, treatment planning, and building
protective factors for affected individuals and their families.
The impact of trauma on individuals with IDD varies greatly
depending on developmental level, which influences the manner in which patients estimate external danger and perceived
threats, as well as their own ability to protect themselves and
maintain safety [23]. Threat perception varies widely in individuals with IDD and engenders thoughts, feelings, and behaviors that can be difficult for caregivers to predict, interpret, or
understand. Perceived threats can relate to heightened negative
attributional biases to facial expressions or tone of voice, or to
fear of separation from loved ones or valued belongings, or to
concerns about somatic symptoms or body integrity, any of
which can be specifically exacerbated by various forms of traumatic life experience. Fear and shame may prevent families
from reporting private and generational trauma or household
dysfunction. Families of children with IDD may also discount
trauma reactions and PS and fail to recognize the impact that
traumatic stress has on the individual or family system. Other
factors that influence family functioning and reporting of trauma are caregiver feelings of inadequacy, grief and loss, differing
opinions about parenting techniques, anticipatory anxiety related to safety of an individual with IDD, stress and strain on
relationships, and caregiver burnout [24].
When traumatic stress underlies PS for an individual with
IDD, supports should incorporate a variety of methods including a focus on principles of positive identity development
(self-identity, self-efficacy) and efforts to build socialemotional learning skills such as self-awareness (identifying
emotions, accurate self-perception, recognizing strengths,
self-confidence, self-efficacy); an emphasis on self-
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management (impulse control, stress management, self-discipline, self-motivation, goal setting, organizational skills); instruction for social awareness (perspective-taking, empathy,
appreciating diversity, respect for others); development of relationship skills (communication, social engagement, relationship building, teamwork); and guidance toward responsible
decision-making (identifying problems, analyzing situations,
solving problems, evaluating, reflecting, ethical responsibility)—all with the goals of promoting resiliency and preventing
future traumatic experiences [25]. All individuals may benefit
when care-providers slow down their speech, use language for
the individual to understand, present information one point at
a time, take frequent pauses to check comprehension, use
multisensory input, make specific suggestions for change, allow the individual some time to practice new skills, avoid
assumptions that the presented information will generalize to
other settings, and include multiple caregivers across various
environments [26]. Building family protective factors is also
key. This can be accomplished by providing support to families that include asking and answering caregiver questions,
providing timely information, addressing traumatic caregiver
experiences, promoting secure attachment, promoting a
healing and protective environment, fostering family-informed, person-centered planning, helping families access
trauma-related supports, partnering with parents to create a
recovery plan, and helping families navigate the challenges
of systems of care [24]. A trauma-informed approach focuses
on safety, trustworthiness, choice, collaboration, empowerment, and cultural competence. Applying these principles
when working with individuals with co-occurring disorders
has been shown to foster resilience and recovery [27].

Aggression
Rates of aggressive behavior are higher in individuals with IDD
than in typically developing peers. Furthermore, the aggressive
behaviors can be more severe, more unpredictable, and more
treatment resistant than in patients without IDD [28, 29].
Aggression in IDD is typically reactive rather than predatory
in nature, but this is not always the case [30]. Aggression in
IDD has been shown to be associated with erosion in social
relationships, exhaustion of social support, placement in restrictive school or residential settings, physical intervention, increased risk of being bullied or victimized, increased stress
levels in caregivers, and decreased quality of life in both the
affected individual and his/her family [2, 31•]. Because changes
in an individual’s environment or routine are common precipitants for aggression, it is also important to be aware of any
significant change with respect to housing, caregivers, school,
or family system impacting the individual. Another common
but often overlooked factor related to aggressive behavior in cooccurring IDD and PS is the inability to effectively
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communicate wants and needs. For such patients, functional
communication training is an indispensable component of appropriate clinical care [32–34]. Functional communication
training involves teaching a socially appropriate communicative response that serves the same function as a problem behavior and therefore serves as a substitute for problem behavior. A
functional analysis is conducted to identify the environmental
events that serve as reinforcers for the problem behavior and the
conditions that evoke problem behavior. A socially appropriate
communicative response is selected and taught with prompting
and a schedule of reinforcement that results in the appropriate
response replacing the problem behavior [32].
In other individuals, aggression is used as a means of communication, for example, to communicate frustration or aversion
to the environment—in this sense, it takes on a functional (rather
than primarily affective) quality for which it is important to invoke positive behavior support strategies designed to reduce and
replace negative behaviors. Neither functional communication
training nor positive behavior support approaches are traditionally prioritized as elements of training in psychiatry or mental
health counseling. Positive behavior support (PBS) planning begins by conducting a functional behavior assessment (FBA),
which provides in-depth information on the function of problematic behaviors, how they are naturally reinforced, and the constellation of experiences that are motivating to a patient [35]. This
information can be incorporated into reward schedules that sustain attempts to replace or help the patient avoid engaging in the
target behaviors. FBAs may include an exposure assessment that
identifies contextual variables that trigger and maintain the aggression and/or impede socially appropriate behavior. Treatment
should focus on reorganizing the environment to proactively
minimize the probability of aggression and increase the probability of alternative/socially appropriate responses through both
antecedent (events that occur before aggression) manipulation,
consequence manipulation, and positive reinforcement strategies
[2]. Noncontingent reinforcement without extinction can be utilized to decrease problem behaviors that are unintentionally
maintained by social positive reinforcement [36, 37].
Mindfulness strategies can be incorporated into PBS plans to
further reduce aggression in patients with dual diagnoses, enabling parents and other caregivers to reduce psychological stress
while helping the patients themselves self-manage challenging
behaviors through PBS. A 40-week study by Singh et al. [38]
evaluated adolescents with ASD (n = 47) or with IDD (n = 45)
and their parents. Results showed significant reductions in aggression and disruptive behavior and increases in compliance
behaviors in the adolescents in both groups and suggested that
the program may be effective regardless of baseline levels of
parental stress.
Medical conditions that incur pain and may not be communicated by a patient with IDD should always be considered in
the differential diagnosis when aggression emerges in patients
with IDD. These include gastrointestinal (GI) distress due to
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constipation or gastro-esophageal reflux, headaches, and sleep
problems including sleep apnea, dental problems, and menstrual pain. Other medical conditions to consider include thyroid
function abnormality and the possibility of epilepsy syndromes
(particularly temporal lobe epilepsy) for which patients with
IDD are disproportionately liable. Untreated medical conditions
in individuals with IDD may result in increased problem behaviors and could lead to overreliance on psychiatric medications to control symptoms. In a very recent case report, a child
with Down syndrome was misdiagnosed and was prescribed
numerous psychiatric medications (clonazepam, venlafaxine,
lamotrigine, ziprasidone, and diazepam) over years of time to
control aggressive behaviors that ultimately resolved when it
was discovered that he had Celiac disease (which disproportionately affects individuals with Down syndrome) and he was
placed on an appropriate diet [39]. He subsequently lost 40
pounds that he had gained from the psychiatric medications,
his GI symptoms improved, and his behavior improved
dramatically.
Psychopharmacologic approaches to the management of aggression in individuals with IDD and PS are an important tool
in the treatment of many patients but should be prescribed only
after consideration of potential environmental precipitants, preceding or ongoing trauma, needs for functional communication
training, and behavior support planning have been carefully
considered. Typically pharmacological treatment proceeds similarly as it would for aggression in psychiatric syndromes exclusive of IDD; mood stabilizing agents (lithium, atypical neuroleptics, and anticonvulsant mood stabilizers) are most effective but carry a diversity of short and long term risks.
Consequently, it may be prudent to consider stimulants and
alpha agonists as first approaches, especially in IDD syndromes
in which aggression may be attributable to ADHD or unspecified impulse control problems; this is particularly common in
the autism spectrum disorders and represents a significant opportunity for safe, effective amelioration of disruptive behaviors. Anxiolytics can be considered for patients whose aggressive episodes occur in the context of unresolved anxiety, with
the caveat that drugs in this class can be disinhibiting and thereby exacerbate aggression in some patients, requiring appropriate caution. There is extensive literature including multiple randomized controlled trials, suggesting that risperidone and
aripiprazole have the strongest evidence in reducing aggression
and irritability in IDD [40]. These interventions can be combined with parent training and other relevant psychosocial interventions to particular advantage [41, 42]. For ASD patients
who have not responded to other antipsychotics, clozapine has
been reported to be an efficacious and well-tolerated treatment
[43]. As IDD syndromes are becoming increasingly specified
by genetic origin through clinical genomic screening, more
specified approaches to aggression in particular IDD syndromes are becoming possible, as in the case of Fragile X
Syndrome, where several agents have been found to be
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effective [44], and new clinical trials involving glutamate receptor antagonists and other agents targeting molecular pathways affected by the condition are under way.

Depression
Depression is common among adolescents and adults with IDD.
Pooled estimation of (a) current and (b) lifetime prevalence for
depressive disorder among adults with ASD are (a) 23% and (b)
37% respectively, and the 2-year incidence of depression in adults
with intellectual disability is on the order of 7.2% [1, 45•].
Whether or not an individual has co-occurring IDD, depression
symptoms may be associated with suicidal ideation and/or selfharming behavior, and it is particularly important in all cases to
ascertain whether there is a family history of attempted or completed suicide given that suicidality is heritable (runs in families) in
a manner that is partially independent from depression itself [46].
When depressive symptoms are accompanied by persistent selfharming behaviors in a patient with IDD, specific positive behavior support algorithms can be applied with exhaustive appraisal
precipitating biological and environmental factors and to manage
these behaviors in accordance with their respective origins [47•].
Common precipitants of depression in IDD are fundamentally similar to those that incur depression in the general population but also have unique features. Loss of a close loved
one is one of the most influential causes of depressive symptoms in all people; in IDD, perceived loss of a caregiver,
friend, or acquaintance who has occupied the role of a close
loved one can be as salient as the death of a relative. The social
and cognitive impairments of an IDD can amplify the perceived salience or importance of a relationship or can result
in misinterpretations of natural life events affecting a relationship (a move, a rebuke, a schedule change). In this context,
“loss” includes the extent to which disruption of a relied-upon
source of interpersonal connection or a sudden increase in
social marginalization has led to a greater degree of “disconnection” from the family, community, society, or social group.
If such an event antedates the onset of depression symptoms,
the treatment approach should reflect what would be invoked
for complicated bereavement (a specific type of adjustment
disorder) and should consider opportunities for “surrogacy”
(i.e., to succeed the individual who was lost).
Individuals with IDD can also experience existential crises
that comprise a set of specific adjustment disorders commonly
encountered during adolescence in neurotypical individuals;
these impinge upon the complex and deeply personal structure
by which a disability has been incorporated into identity, and can
often be associated with depressed mood [48, 49]. The themes of
existential crises tend to revolve around concerns pertaining to
mortality (fear of death or denial of death by risk-taking),
meaninglessness (concern that limitations of one’s ability severely jeopardize meaning or purpose), isolation, or the perceived
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inability to make a choice. The latter refers to situations in which
agency, or the capacity to direct one’s own course has been violated (the notion of being controlled or “managed” as if a puppet).
It is common for individuals with IDD to encounter circumstances in which limitation, marginalization, or loss of control
dominate day-to-day experience. When such experiences play a
role in precipitating depressive states, the intervention approach
must include addressing the existential concern being experienced by the individual in an age- and developmentally appropriate manner and avoiding the assumption that the individual is
incapable of formulating or struggling with such concerns.
Peers and the environment fundamentally shape self-perception and the manner in which a disability is incorporated
into an individual’s identity. Many children and adolescents
with IDD recognize differences between themselves and their
peers, and this recognition can be correlated with higher levels
of depressive symptoms. Verbally fluent youth with autism
who perceived that they had the lowest group membership
and social integration have been reported to have elevated
levels of depressive symptoms, and these represent targetable
precipitants in strategies to treat depression in IDD [50, 51].
Negative peer interactions have been shown to exert independent adverse effects, especially on children with IDD who are
very commonly bullied, teased, or ostracized in educational
settings. Peer victimization and depressive symptomatology
have been widely correlated, and observational studies document both social isolation and distress as direct consequences
of being bullied in the school environment. Interpersonal conflict with family members has also been strongly associated
with depressive symptomatology. Social marginalization and
sedentary lifestyles compound liability for depression and
must be addressed in any comprehensive approach to the treatment of depression including those with a dual diagnosis.
Young adults with ASD without an intellectual disability are
3 times more likely to have “no daytime activities” compared
with adults with ASD with an intellectual disability, demonstrating how inadequacy of current service systems to meet the
needs of autistic youth without IDD compounds risk for the
development/entrenchment of depressive syndromes.
The approach to management of depression in IDD hinges on
specification of precipitating factors and careful consideration in
ruling out potential medical contributors such as hypothyroidism,
chronic pain, epilepsy, insomnia, and catatonia syndromes that
are common to some IDDs such as Down syndrome. Catatonia
in Down syndrome (which involves social withdrawal) has been
responsive to interventions that would not necessarily be considered as first-line therapy for patients manifesting depression—
such interventions include judicious use of lorazepam, electroconvulsive therapy, and glutamate antagonists [52]. Intervention
must be tailored to the individual’s verbal abilities, developmental level, interests, and goals. It is important to recognize that
higher verbal/cognitive abilities and greater social insight are
associated with lower self-perceived social competence and
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subsequently higher rates of depression [53]. Individuals with
IDD and depression benefit from environmental supports to mitigate the impact of precipitating experiences and improve social
connectedness and self-determination. A recent review in this
journal summarized the literature on psychosocial treatments
for anxiety and depression in autism spectrum disorder,
highlighting established efficacy of cognitive behavioral therapy
(CBT) for anxiety, but few studies have examined the effect of
the intervention for depression per se [54•]. There are few studies
of good quality evaluating non-pharmacological interventions
for adults with IDD and depression; however, the existing studies
on CBT show good results in decreasing depressive symptoms
[55•]. Additionally, behavioral activation (prescribed engagement in productive activities) with guided self-help treatments
has been found effective in reducing depressive symptomatology
[56]. This aligns with the literature on behavioral activation as a
key mechanism in many CBT programs for individuals with and
without IDD [57]. Vocational rehabilitation can be a key support
for adults whose depressive symptoms relate to social marginalization, a sense of meaninglessness of daily routines (an existential concern), and/or absence of opportunity to participate meaningfully in the community.
Psychopharmacology and other somatic therapies may be
beneficial in treating depression for individuals with IDD, although data are limited. Extrapolation of published effects of
antidepressant medications in the psychiatry literature justifies
psychopharmacologic treatment for dual diagnosis patients when
the modalities described above have been considered and/or
failed. Psychopharmacology of depression in IDD is similar to
that implemented for major depression in neurotypical individuals, with the exception of dose-adjustments for conditions associated with abnormal drug metabolism or sensitivity to adverse
effects. Studies of the efficacy of the various classes of antidepressant medication in IDD are sparse and in many cases limited
to case series, but use of these approaches is both reasonable and
potentially life-saving when psychosocial strategies have been
unsuccessful in reducing severe depression symptoms.
Medication classes for treatment of depression include the antidepressants (SSRI’s, SNRI’s, tricyclics, MAO inhibitors, and
bupropion), as well as mood stabilizers for adjunctive therapy
in treatment-resistant depression (lithium, neuroleptic mood stabilizers, and the anticonvulsants).

The Addictions
Similar to neurotypical peers, individuals with IDD often start
explorative substance use in adolescence (between ages 14–16)
yet exhibit lower tolerance for recreational substance use and are
at a heightened risk for adverse consequences depending upon
intellectual, social, and communicative levels of functioning [3,
58]. It is important to understand the spectrum of substance
activity/use, which ranges from recreational and non-
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problematic use to at-risk/problematic use to severe misuse/dependency. Recreational and explorative use will present differently than risky or problematic and harmful misuse. Furthermore,
contextual specifics (such as age or cognitive functioning level)
are important to consider when determining severity of substance
activity/use, especially in scenarios where access to illicit drugs
constitutes a form of neglect or endangerment by the caregiving
environment. In addition to substance abuse, excessive and
problematic engagement in other specific behaviors (e.g., video
gaming, pornography) are included within the addictions
umbrella; although detailed coverage of these conditions is
beyond the scope of this review, they overlap in many aspects
of phenomenology and in psychosocial approaches to treatment
[59, 60].
The assessment of patterns of substance use in individuals
with IDD requires systematic review of access, safety concerns, and respect for autonomy and decision-making.
Typically it is important to clinically ascertain what happens
before—e.g., boredom versus withdrawal symptomatology
versus co-occurring activities where other people are engaging
in substance activity/use—and after substance activity/use,
including physiological (e.g., “high” or “drunk” or arousal),
social (e.g., social isolation or high-quality social interaction),
and psychological (e.g., emotional/mood swings) effects.
Immediate and delayed positive and negative consequences
of substance activity/use should be reviewed.
Use of harm-reduction strategies or reduction of use over time
constitute the prevailing strategies for treating clients with IDD
and substance use disorders [58]. When considering harmreduction strategies, clinicians must target frequency of use,
quantity (or amount of time engaged in activity) of use, duration
of time between use, and the safety of the environment (e.g.,
absolute avoidance of driving while intoxicated, restricting recreational substance use to circumstances/settings that minimize
risk for predation, exploitation, or self-endangerment in the context of use). Service providers should consider cross-training
staff/caregivers on risks and vulnerabilities of clients with IDD,
including peer pressure and exploitation, deficits in self-determination, and aspects of autonomy in recreational use. Despite
substantial rates of addiction among adolescents and adults with
IDD, evidence for the effectiveness of specific therapies varies,
and the field is still maturing. There is emerging evidence that
modified versions of CBT and motivational interviewing are
capable of decreasing aspects of substance activity/use [61•,
62]. Clinicians providing CBT to patients with IDD should be
aware of modifications that have improved its application to this
subpopulation, and monthly group supervision has been helpful
in implementing such modifications [61], which include
enhancement in structure, directive strategies, increased
number of sessions, and adaptations to meet the
communication and comprehension needs of individual clients.
Functional behavior assessments and corresponding behavioral intervention plans have also been shown to be
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Table 2 Listing of selected clinical trials and systematic reviews, publication dates 2014–2019, documenting evidence for specific intervention
modalities for ASD/ID and aggression, depression, or addictions
Title

IDD and aggression
Aggression in autism spectrum disorder:
presentation and treatment options
Shaping complex functional
communication responses

Noncontingent reinforcement without
extinction plus differential reinforcement
of alternative behavior during treatment
of problem behavior
Meta-analysis of noncontingent
reinforcement effects on problem behavior

Effects of mindfulness-based positive
behavior support (MBPBS) training are
equally beneficial for mothers and their
children with autism spectrum disorder
or with intellectual disabilities
Pharmacologic treatment of severe irritability
and problem behaviors in autism: a
systematic review and meta-analysis
Effect of parent training vs parent education
on behavioral problems in children with
autism spectrum disorder: a randomized
clinical trial
11 years of clozapine experience in autism
spectrum disorder: efficacy and tolerance
Pharmacologic interventions for irritability,
aggression, agitation, and self-injurious
behavior in Fragile X Syndrome:
an initial cross-sectional analysis

Lead author; Year; Citation
number in reference list

Intervention modalities

Fitzpatrick et al.
Neuropsychiatric Disease
and Treatment 2016 [2]
Ghaemmaghami et al.
Journal of Applied
Behavior Analysis 2018
[36]
Fritz et al. Journal of Applied
Behavior
Analysis 2017 [12]

-Functional behavioral assessment
-Reinforcement strategies
-Functional communication training
-Shaping
-Functional communication training
-Complex functional communication responses

Richman, et.al, Journal of
Applied
Behavior Analysis 2015
[38]
Singh et al. Frontiers in
Psychology 2019 [39]

Fung et al. Pediatrics 2016
[41]

-Noncontingent reinforcement without
extinction
-Differential reinforcement of alternative
behavior
-Positive behavior support planning

-Mindfulness to reduce perceived
psychological
stress for both caregivers and children with
IDD
-Positive behavior support
-Risperidone
-Aripiprazole

Bearss et al., JAMA 2015 [42] -Behavioral parent training

Rothärmel et al. J Clin
Psychopharmacol 2018
[43]
Eckert et al. J Autism Dev
Disord 2019 [44]

-Clozapine

Minshawi et al. J Autism
Dev Disord 2015 [47•]

-Applied behavior analysis (ABA)-based
positive behavior supports
-Psychopharmacologic intervention

Miles JH et al.
Neuropsychiatr
Dis Treat 2019 [52]

-Pharmacotherapy and electroconvulsive
therapy (ECT)

Hamers et al. Journal of
Intellectual
Disability Research 2018
[55]

-Cognitive behavioral therapy
-Behavioral therapy
-Exercise intervention
-Social problem-solving skills program
-Bright light therapy
-Individual psychological interventions:
BeatIt and StepUp

-Antipsychotic medications, specifically
aripiprazole and risperidone

IDD and Depression
Multidisciplinary assessment and treatment
of self-injurious behavior in autism
spectrum disorder and intellectual
disability: integration of psychological
and biological theory and approach
Catatonia in Down syndrome: systematic
approach to diagnosis, treatment and
outcome assessment based on a case
series of seven patients
Non-pharmacological interventions for
adults with intellectual disabilities
and depression: a systematic review

Comparison of behavioral activation with
guided self-help for treatment of
depression in adults with intellectual
disabilities: a randomized controlled trial

Jahoda et al. Lancet
Psychiatry 2017 [56]
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Table 2 (continued)
Title

Adapting cognitive behavioral techniques
to address anxiety and depression in
cognitively able emerging adults on
the autism spectrum

Lead author; Year; Citation
number in reference list

Intervention modalities

Kerns et al. Cognitive and
Behavioral
Practice 2016 [57]

-Cognitive behavioral therapy

Crosby et al. Behavior
Therapy. 2016 [60]
Wölfling et al. JAMA
Psychiatry 2019 [59]

-Acceptance and commitment therapy

IDD and addictions
Acceptance and commitment therapy for problematic internet
pornography use: a randomized trial
Efficacy of short-term treatment of
internet and computer game addiction:
a randomized clinical trial
Treating patients with co-occurring autism spectrum disorder and
substance use disorder: a clinical explorative study

A feasibility randomized controlled trial
of extended brief intervention for
alcohol misuse in adults with mild
to moderate intellectual disabilities
living in the community;
the EBI-LD study

-Short-term, manualized cognitive behavioral
therapy, specifically adapted
for internet/computer game
addiction
Helverschou et al. Substance -Cognitive behavioral therapy
Abuse:
-Monthly ASD education and group
Research and Treatment
supervision to therapists in
2019 [61]
substance use clinics
Kouimtsidis et al. Trials 2017 -Manualized motivational enhancement
[63]
therapy incorporating principles of CBT

effective at decreasing substance activity/use and can be
useful approaches for IDD patients struggling with
a dd i cti on . To m i n i m i z e av ers i v e e xp er i en ce s o f
detoxification (for substance use) and withdrawal (for
substance and activity use), treatment should target small
successive reductions of substance activity/use over time
(i.e., harm reduction), with a long-term goal of abstinence or
controlled/responsible use. Goals and timeline to abstinence
of substance activity/use should be client-specific and should
operationalize harmful levels of use at the beginning of treatment. Group treatment for substance use, such as “12-step”
programs, lacks strong evidence for individuals with IDD but
can be considered on a case-by-case basis. Mandated participation in group sessions may provoke anxiety or anger among
individuals with IDD, leading to dropout, rejection by other
group members, and induced feelings of failure and exclusion
[3]. Motivational enhancement therapy incorporating principles of CBT has shown promise for individuals with IDD
experiencing problems related to alcohol misuse:
Kouimtsidis et al. conducted a randomized controlled trial of
extended brief intervention among subjects whose drinking
exceeded a threshold for safety; at 12 weeks following the
intervention, the proportion of participants with harmful
drinking had decreased by 66.7% and 46.7% for the intervention and the control groups, respectively [63].

Conclusions
Our review identified a number of recent translational advances in the management of specific psychiatric syndromes in individuals with autism—fewer in those with
intellectual disability—and very few scientific articles in
which comprehensive approaches to symptom identification/interpretation, diagnosis, and treatment of specific
combinations IDD and PS were implemented and evaluated. The evidence base summarized here emphasizes the
importance of tailoring the management of psychiatric
syndromes to the unique context of a given intellectual
or developmental disability, considering the widely varying consequences of such conditions on capacity for communication and engagement in intervention, the function
of behavioral impairment, and the manner in which psychiatric symptoms manifest. Table 2 provides a listing of
selected clinical trials and systematic reviews, published
over the past 5 years, documenting evidence for specific
intervention modalities for ASD/ID and aggression, depression, or addictions. Symptom identification must include careful consideration of precipitating factors for psychiatric symptoms that are accentuated in the context of
developmental disability and the increased vulnerability to
and impact of trauma. Factors that may be less easily
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communicated by IDD populations must be considered in
diagnostic formulation, including traumatic experiences
that may be viewed by the community as relatively trivial,
medical conditions that incur pain, and the recognition of
differences between individuals with IDD and their peers.
Intervention strategies must cross the boundaries of what
are typically applied to IDD versus PS, using comprehensive approaches such as positive behavior support planning, functional behavior assessments, applied behavior
analysis-based interventions, cognitive behavioral therapy,
in-home therapeutic support, case management, and psychopharmacologic therapy. It is clear that more research is
needed for understanding the impact of treatment and improving best practice in these common complex syndromes, as represented by combinations of IDD with three
common, serious behavioral syndromes covered in relative
detail here—aggression, depression, and addictions. As we
await advances in evidence-informed approaches to these
conditions, bridging gaps in knowledge across the respective IDD and PS service sectors should be of very high
priority to empower clinicians, patients, and their families
to seek treatments that cross traditional bureaucracies of
care and integrate disparate intervention modalities (including positive behavior supports, pharmacotherapy, appropriately modified psychotherapy, and trauma-informed
care). These intervention modalities should be advocated
for implementation within the treatment plans for individual patients whose complex conditions are unnecessarily
protracted or aggravated when there exists unrecognized
opportunity for better treatment outcome, i.e., when comprehensive approaches harnessing all available evidenceinformed interventions have not yet been considered and
applied.
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